Your browser doesn't support javascript.
loading
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Kotsopoulos, Joanne; Gronwald, Jacek; Huzarski, Tomasz; Aeilts, Amber; Randall Armel, Susan; Karlan, Beth; Singer, Christian F; Eisen, Andrea; Tung, Nadine; Olopade, Olufunmilayo; Bordeleau, Louise; Eng, Charis; Foulkes, William D; Neuhausen, Susan L; Cullinane, Carey A; Pal, Tuya; Fruscio, Robert; Lubinski, Jan; Metcalfe, Kelly; Sun, Ping; Narod, Steven A.
Afiliação
  • Kotsopoulos J; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
  • Gronwald J; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Huzarski T; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Aeilts A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Randall Armel S; Division of Human Genetics, The Ohio State University Medical Center, Comprehensive Cancer Center, Columbus, OH, USA.
  • Karlan B; Bhalwani Familial Cancer Clinic, Princess Margaret Cancer Centre, Toronto, Canada.
  • Singer CF; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Eisen A; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
  • Tung N; Department of Obstetrics and Gynecology and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Olopade O; Toronto-Sunnybrook Regional Cancer Center, Toronto, ON, Canada.
  • Bordeleau L; Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Eng C; Department of Medicine and Human Genetics, University of Chicago, Chicago, IL, USA.
  • Foulkes WD; Department of Oncology, Juravinski Cancer Centre and McMaster University, Hamilton, ON, Canada.
  • Neuhausen SL; Genomic Medicine Institute and Center for Personalized Genetic Healthcare, Cleveland Clinic, Cleveland, USA.
  • Cullinane CA; Department of Oncology, McGill Program in Cancer Genetics, McGill University, Montreal, QC, Canada.
  • Pal T; Division of Biomarkers of Early Detection and Prevention, City of Hope, Duarte, USA.
  • Fruscio R; Todd Cancer Institute, Long Beach Memorial Hospital, Long Beach, CA, USA.
  • Lubinski J; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Metcalfe K; Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, University of Milan Bicocca, Monza, Italy.
  • Sun P; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Narod SA; Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
Breast Cancer Res Treat ; 201(2): 257-264, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37432545
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá